Challenges in Balancing Treatment of OFF Episodes and Dyskinesia in Parkinson Disease

EP: 1.Treatment Options for Parkinson Disease EP: 2.Use of Parkinson Disease Treatments and Identification of OFF Episodes in Clinical Practice EP: 3.Challenges With Parkinson Disease Treatments EP: 4.Pathophysiology of Dyskinesia in Parkinson Disease EP: 5.Risk Factors for Dyskinesia in Patients Wi...

Full description

Saved in:
Bibliographic Details
Published inNeurology live (Print)
Main Author Kremens, Daniel E
Format Journal Article
LanguageEnglish
Published Cranbury Intellisphere, LLC 25.04.2023
MultiMedia Healthcare Inc
Subjects
Care and treatment
Dopamine
Dyskinesia
Medical research
Medicine, Experimental
Neurology
Parkinson's disease
Patients
Online AccessGet full text

Cover

More Information
Summary:EP: 1.Treatment Options for Parkinson Disease EP: 2.Use of Parkinson Disease Treatments and Identification of OFF Episodes in Clinical Practice EP: 3.Challenges With Parkinson Disease Treatments EP: 4.Pathophysiology of Dyskinesia in Parkinson Disease EP: 5.Risk Factors for Dyskinesia in Patients With Parkinson Disease EP: 6.Diagnosis of Dyskinesia and Impact on Quality of Life of Patients With Parkinson Disease Now Viewing EP: 7.Challenges in Balancing Treatment of OFF Episodes and Dyskinesia in Parkinson Disease EP: 8.Treatment of Dyskinesia in Patients with Parkinson's Disease EP: 9.Amantadine Formulations in Treatment of Dyskinesia in Parkinson Disease EP: 10.Studies With Amantadine-DR/ER for Treatment of Dyskinesia Daniel E. Kremens, MD, JD: Bill, do you think there are any long-term consequences potentially or complications for delaying treatment of dyskinesia? The DR/ER [delayed-release/extended-release] preparation of amantadine is the only medicine to my knowledge that has been proven to help both with reducing OFF time and reducing dyskinesia, so that's one of the options in that population.
ISSN:2767-4258
2767-4266